Austco Healthcare Limited

AHC.ASX

Health Care

Manufacture, service, supply and distribution of Healthcare and communications equipment.

Market Data

Price

$0.300

-0.0%
Market Cap

$112.4M

P/E Ratio

14.5x

EPS

$0.021

Div. Yield

0.00%

52-Week Change

-0.2%

Latest Earnings

Appendix 4D and 1HFY26 Accounts

18 February 2026

Revenue
$48.20
+30.7% YoY
NPAT
$4.70
+61.7% YoY
EPS
$0.01

Austco Healthcare delivered record first-half revenue of $48.2M, up 30.7% driven by recent acquisitions and strong organic growth. EBITDA surged 60% to $8.3M with margins expanding 310bp to 17.1%, while NPAT increased 61.7% to $4.7M. The company maintains a strong balance sheet with $15.2M cash and no debt, positioning it well for continued growth despite not paying dividends. Key points: Record revenue of $48.2M up 30.7% with strong organic growth of 10% in ANZ and 37% in North America; EBITDA margins expanded significantly by 310bp to 17.1% demonstrating operational leverage and scale benefits; Strong cash generation of $9.2M from operations while maintaining debt-free balance sheet with $15.2M cash

Recent Announcements

18 Feb 2026 Supplementary Positive

Half Year results investor presentation

Austco Healthcare delivered strong 1H-26 results with revenue growing 30.7% to $48.2m and EBITDA surging 60.1% to $8.3m, demonstrating significant operating leverage. The company benefits from structural healthcare digitization tailwinds and maintains a debt-free balance sheet with $15.2m cash and $47.2m unfilled contracted revenue providing earnings visibility. Growth was driven by successful acquisition integration alongside organic expansion, particularly in North America and ANZ. Key points: Strong operating leverage with EBITDA growing 60.1% vs revenue growth of 30.7%; EBITDA margin expansion from 14.0% to 17.1%, demonstrating scale benefits; Debt-free balance sheet with $15.2m cash providing financial flexibility

18 Feb 2026 Supplementary Positive

Half Year results media release

Austco Healthcare delivered record 1H26 results with revenue growing 31% to $48.2 million and EBITDA surging 60% to $8.3 million. The company demonstrated strong operating leverage with EBITDA margins expanding 310 basis points to 17.1%, while maintaining a debt-free balance sheet with $15.2 million cash. The outlook remains positive with $47.2 million in unfilled contracted revenue providing earnings visibility. Key points: Record revenue growth of 30.7% to $48.2 million driven by acquisitions and organic growth; EBITDA margin expansion of 310 basis points to 17.1% demonstrating strong operating leverage; Debt-free balance sheet with $15.2 million cash providing financial flexibility

18 Feb 2026 Actual Results Positive

Appendix 4D and 1HFY26 Accounts

Austco Healthcare delivered record first-half revenue of $48.2M, up 30.7% driven by recent acquisitions and strong organic growth. EBITDA surged 60% to $8.3M with margins expanding 310bp to 17.1%, while NPAT increased 61.7% to $4.7M. The company maintains a strong balance sheet with $15.2M cash and no debt, positioning it well for continued growth despite not paying dividends. Key points: Record revenue of $48.2M up 30.7% with strong organic growth of 10% in ANZ and 37% in North America; EBITDA margins expanded significantly by 310bp to 17.1% demonstrating operational leverage and scale benefits; Strong cash generation of $9.2M from operations while maintaining debt-free balance sheet with $15.2M cash

Get real-time alerts for AHC

Receive AI-powered earnings summaries and instant notifications when Austco Healthcare Limited releases results.

Register Free